Skip to main content
V

Viracoat

The startup has developed an antiviral and antimicrobial coating material (ACM) that effectively inactivates SARS-CoV-2, influenza, and various bacteria on surfaces. This technology significantly reduces the transmission of infectious diseases in high-contact environments.

Lancaster, United States
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • The startup has developed an antiviral and antimicrobial coating material (ACM) that effectively inactivates SARS-CoV-2, influenza, and various bacteria on surfaces. This technology significantly reduces the transmission of infectious diseases in high-contact environments.
This profile is AI-generated and may contain inaccuracies.